Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study
Author:
Funder
National Institute for Health Research
Publisher
Elsevier BV
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference42 articles.
1. Immune checkpoint inhibitors: an innovation in immunotherapy for the treatment and management of patients with cancer;Dine;Asia Pac J Oncol Nurs,2017
2. What are “checkpoint” immunotherapy drugs?,2015
3. Cancer immunotherapy;Couzin-Frankel;Science,2013
4. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: Results from a randomized, double-blind, multicenter phase II study;Lynch;J Clin Oncol,2012
5. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review;Health Economics Review;2024-07-05
2. Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know;PharmacoEconomics;2024-07-05
3. Challenges, considerations, and approaches for developing a cost-effectiveness model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a spotlight on nivolumab versus placebo;Journal of Medical Economics;2024-03-25
4. A Cost-effectiveness analysis of Nivolumab plus chemotherapy for the first-line treatment of locally advanced or metastatic gastric/GEJ/oesophageal adenocarcinoma in the United States of America;2024-02-27
5. Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry;Medical Decision Making;2024-02-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3